We are live on ! Find out more
RM

RP Management Portfolio holdings

AUM $139M
1-Year Est. Return 37.98%
This Fund
S&P 500
This Quarter Est. Return
+74.59%
1 Year Est. Return
-37.98%
3 Year Est. Return
+207.8%
5 Year Est. Return
+1,098.05%
10 Year Est. Return
–
AUM
$667M
AUM Growth
+$150M
Cap. Flow
+$291K
Cap. Flow %
0.04%
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
1
Reduced
–
Closed
–
Avg Time Held Equity + Options
5.7 quarters
Top 10 Avg Time Held Equity + Options
5.7 quarters
Top 20 Avg Time Held Equity + Options
5.7 quarters
Avg Time Held Equity only
6.2 quarters
Top 10 Avg Time Held Equity only
6.2 quarters
Top 20 Avg Time Held Equity only
6.2 quarters

Top Buys

Rank Stock Value
1
VIRX icon
Viracta Therapeutics, Inc. Common Stock
VIRX
+$291K

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 95.53%
2 Miscellaneous 4.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
IMMU
1
DELISTED
Immunomedics Inc
IMMU
$372M 55.73%
4,373,178
– –
2018 Q4
7 quarters
BHVN icon
2
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$137M 20.57%
2,111,111
– –
2018 Q4
7 quarters
EPZM
3
DELISTED
Epizyme, Inc
EPZM
$109M 16.39%
9,166,667
– –
2019 Q4
3 quarters
EPZM
4
CALL
DELISTED
Epizyme, Inc
EPZM
$29.8M 4.47%
2,500,000
– –
2019 Q4
3 quarters
CYTK icon
5
Cytokinetics
CYTK
$8.76B
$19M 2.84%
875,656
– –
2018 Q4
7 quarters
VIRX icon
6
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$16K ﹤0.01%
37,005
+33,305
+900% +$291K
2018 Q4
7 quarters

Similar funds

PC
Paradoxiom Capital Stamford, Connecticut $154M AUM
LA
LPF Advisors Sarasota, Florida $122M AUM 3.12% 1-Year Est. Return
TP
Thunderbird Partners London, United Kingdom $113M AUM 8.51% 1-Year Est. Return
SC
Serenity Capital Palo Alto, California $167M AUM
MADFP
Michael A Dubis Financial Planning Middleton, Wisconsin $103M AUM
RM
RCF Management Denver, Colorado $103M AUM
NC
Napatree Capital Westerly, Rhode Island $178M AUM 8.09% 1-Year Est. Return
GWA
GGM Wealth Advisors Baltimore, Maryland $180M AUM 10.57% 1-Year Est. Return

RP Management's Q3 2020 Portfolio in Review

As of Q3 2020, RP Management held 6 positions worth $667M, up 29% from $517M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q3 2020: portfolio turnover was 0%. RP Management opened no new positions and made no exits, leaving the 6-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 96% of assets, up from 92% a quarter earlier, followed by Miscellaneous.

  • RP Management added most to Viracta Therapeutics, Inc. Common Stock in Q3 2020, an estimated $291K increase.
  • RP Management's ten largest holdings make up 100% of its $667M portfolio in Q3 2020.
  • RP Management opened 0 new positions and closed 0 in Q3 2020.
  • RP Management's portfolio value rose 29% quarter-over-quarter to $667M.

Based on RP Management's 13F filing for Q3 2020, filed 12 Nov 2020.